Myeloproliferative Neoplasms (Essential Thrombocythemia, Polycythemia Vera)
Conditions
Interventions
Hematology Physicians:None
Sponsors
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Hematology Physicians: 1. Having experience in managing MPN patients within the past 12 months, defined as having diagnosed and treated at least 8 MPN patients in the past 12 months, including at least 2 patients with PV and at least 4 patients with ET. 2. All participants must provide informed consent or read through the Participant Info Letter. Patients: 1. Aged =18 years ; 2. Diagnosed with PV or ET by clinic visit; 3. Patients who have received treatment; 4. All subjects must provide informed consent or read through the Participant Info Letter.
Exclusion criteria
Exclusion criteria: Patients are currently receiving Merck/MSD therapy or therapy with drugs in the same class.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease Characteristics of ET/PV Patients;Treatment Patterns in ET/PV Patients;Diagnostic Journey and Decision-Making Factors; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease Burden and Quality of Life;Unmet Clinical Needs; | — |
Countries
China
Contacts
Public ContactZhang Lei
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Outcome results
None listed